Works matching IS 0008543X AND DT 2019 AND VI 125 AND IP 18


Results: 24
    1
    2
    4
    5
    6
    8
    9
    10
    11
    12

    Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancer.

    Published in:
    2019
    By:
    • Martini, Alberto;
    • Jia, Rachel;
    • Ferket, Bart S.;
    • Waingankar, Nikhil;
    • Plimack, Elizabeth R.;
    • Crabb, Simon J.;
    • Harshman, Lauren C.;
    • Yu, Evan Y.;
    • Powles, Thomas;
    • Rosenberg, Jonathan E.;
    • Pal, Sumanta K.;
    • Vaishampayan, Ulka N.;
    • Necchi, Andrea;
    • Wiklund, N. Peter;
    • Mehrazin, Reza;
    • Mazumdar, Madhu;
    • Sfakianos, John P.;
    • Galsky, Matthew D.
    Publication type:
    journal article
    13

    Early squamous cell carcinoma of the oral tongue with histologically benign lymph nodes: A model predicting local control and vetting of the eighth edition of the American Joint Committee on Cancer pathologic T stage.

    Published in:
    2019
    By:
    • Sridharan, Shaum;
    • Thompson, Lester D. R.;
    • Purgina, Bibianna;
    • Sturgis, Charles D.;
    • Shah, Akeesha A.;
    • Burkey, Brian;
    • Tuluc, Madalina;
    • Cognetti, David;
    • Xu, Bin;
    • Higgins, Kevin;
    • Hernandez‐Prera, Juan C.;
    • Guerrero, Dominick;
    • Bundele, Manish M.;
    • Kim, Seungwon;
    • Duvvuri, Umamaheswar;
    • Ferris, Robert L.;
    • Gooding, William E.;
    • Chiosea, Simion I.;
    • Hernandez-Prera, Juan C
    Publication type:
    journal article
    14
    16
    17
    18
    19

    Issue Information.

    Published in:
    Cancer (0008543X), 2019, v. 125, n. 18, p. 3087, doi. 10.1002/cncr.31618
    Publication type:
    Article
    20

    Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial.

    Published in:
    2019
    By:
    • Haddad, Robert;
    • Concha‐Benavente, Fernando;
    • Blumenschein, George;
    • Fayette, Jerome;
    • Guigay, Joel;
    • Colevas, A. Dimitrios;
    • Licitra, Lisa;
    • Kasper, Stefan;
    • Vokes, Everett E.;
    • Worden, Francis;
    • Saba, Nabil F.;
    • Tahara, Makoto;
    • Jayaprakash, Vijayvel;
    • Lynch, Mark;
    • Li, Li;
    • Gillison, Maura L.;
    • Harrington, Kevin J.;
    • Ferris, Robert L.;
    • Concha-Benavente, Fernando;
    • Blumenschein, George Jr
    Publication type:
    journal article
    21
    22
    23
    24

    A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.

    Published in:
    2019
    By:
    • Patil, Vijay Maruti;
    • Noronha, Vanita;
    • Joshi, Amit;
    • Agarwal, Jaiprakash;
    • Ghosh‐Laskar, Sarbani;
    • Budrukkar, Ashwini;
    • Murthy, Vedang;
    • Gupta, Tejpal;
    • Mahimkar, Manoj;
    • Juvekar, Shashikant;
    • Arya, Supreeta;
    • Mahajan, Abhishek;
    • Agarwal, Archi;
    • Purandare, Nilendu;
    • Rangarajan, Venkatesh;
    • Balaji, Arun;
    • Chaudhari, Sameer Vasant;
    • Banavali, Shripad;
    • Kannan, Sadhana;
    • Bhattacharjee, Atanu
    Publication type:
    journal article